Related Experiment Video
Updated: Feb 22, 2026
Establishment and Characterization of UTI and CAUTI in a Mouse Model
Published on: June 23, 2015
An update on new antibiotic prophylaxis and treatment for urinary tract infections in children
Jean Daniel Delbet1,2, Mathie Lorrot3, Tim Ulinski1,2
1a Pediatric Nephrology Unit , Trousseau Hospital and DHU i2B Inflammation-Immunopathology-Biotherapy , Paris , France.
Insights
Prompt treatment for pediatric urinary tract infections (UTIs) like pyelonephritis and cystitis is crucial, but not for asymptomatic bacteriuria. Early antibiotic intervention in pyelonephritis prevents renal scars, while avoiding overuse of certain antibiotics is key due to rising resistance.
Area of Science:
- Pediatric Nephrology
- Infectious Diseases
- Clinical Pediatrics
Background:
- Urinary tract infections (UTIs) in children require careful differentiation between acute pyelonephritis, acute cystitis, and asymptomatic bacteriuria.
- Prompt antibiotic treatment is essential for pyelonephritis and cystitis to prevent complications like renal scarring.
- Asymptomatic bacteriuria in children does not necessitate immediate treatment and should be managed to avoid selecting for more virulent strains.
Purpose of the Study:
- To review recent changes in the management of pediatric urinary tract infections.
- To emphasize the importance of distinguishing between different types of UTIs for appropriate treatment strategies.
- To highlight emerging challenges in pediatric UTI treatment, including antibiotic resistance.
Main Methods:
- Literature review focusing on recent advancements in pediatric UTI treatment guidelines.
- Analysis of diagnostic criteria and therapeutic approaches for acute pyelonephritis, cystitis, and asymptomatic bacteriuria.
- Discussion of predisposing factors and the impact of antibiotic resistance on treatment selection.
Main Results:
- Increasing resistance to 3rd generation cephalosporins necessitates avoiding their overuse in low-risk pediatric UTI cases.
- The prevalence of extended-spectrum beta-lactamase (ESBL) producing E. coli infections is rising in children, requiring specific treatment awareness.
- Evaluation of predisposing conditions like voiding anomalies and urinary tract malformations is critical for comprehensive UTI management.
Conclusions:
- Distinguishing between UTI types is paramount for effective pediatric management.
- Antibiotic stewardship is crucial, especially concerning 3rd generation cephalosporins and ESBL-producing organisms.
- Treatment recommendations for pediatric UTIs must be regularly updated based on local resistance patterns and economic factors.
Introduction:
This review focuses on the treatment of urinary tract infections (UTI) in children and in particular its recent changes. Areas covered: Acute pyelonephritis, acute cystitis and asymptomatic bacteriuria or asymptomatic infections have to be clearly distinguished. Prompt treatment is required in pyelonephritis and cystitis, but not in asymptomatic bacteriuria or infection, in order to avoid selection of more virulent strains. This concept should be considered even in immunocompromised or bedridden children. In case of pyelonephritis, there should be no delay in beginning the antibiotic treatment in order to decrease the risk of long term complication, such as renal scars. Predisposing conditions for UTI, such as voiding anomalies and urinary tract malformation should be carefully evaluated. Expert opinion: One major concern is the increasing resistance to 3rd generation cephalosporins. Therefore overconsumption in low-risk settings should be absolutely avoided. The prevalence of infections with E. coli producing extended spectrum ß-lactamase (ESBL) is increasing and pediatricians should be aware about the specific treatment options. Any recommendation about (initial) antibiotic treatment should be regularly updated and adapted to local resistance profiles and to economic factors in different health systems.
Related Concept Videos
01:30Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
01:17Urinary Tract Infection IV: Nursing Management
01:26Urine Studies II: Urine Culture and Sensitivity Test
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
01:26Urinary Tract Infection I: Introduction